Dr. Benhammou completed her undergraduate studies at the University of Texas at Austin, with a major in human biology. She then completed medical school at University of California, San Francisco with a thesis in molecular medicine. Before starting her internship at the University of California, Los Angeles in internal medicine, Dr. Benhammou participated in a two-year intramural program at the National Cancer Institutes studying functional genomics and hereditary forms of kidney cancer.
Dr. Benhammou went on to complete her internal medicine and gastroenterology training at UCLA. There, she received advanced research training in the UCLA Specialty Training and Advanced Research (STAR) program and NIH T32, which supported her graduate studies in the Department of Molecular, Cellular, and Integrative Physiology. Her doctoral dissertation addressed the clinical risk factors of NAFLD hepatocellular carcinoma and the molecular mechanisms at play in NAFLD pathogenesis. Following her PhD, Dr. Benhammou completed additional clinical training in transplant hepatology at UCLA.
Dr. Benhammou joined the digestive diseases and hepatology faculty at UCLA and Greater Los Angeles VA where she will care for patients with chronic liver disease before and after liver transplantation. She will continue to pursue her research on NAFLD-associated hepatocellular carcinoma using clinical and translational research tools. She is board certified in internal medicine, gastroenterology and transplant hepatology.